The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Open accessAbstract
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–225 of 225
Pino, M. V., Kelley, M. F., & Jayyosi, Z. (2004) · Toxicologic Pathology · doi:10.1080/01926230490261320 · Cited by 35
Borland, M. G., Khozoie, C., Albrecht, P. P., Zhu, B., Lee, C., Lahoti, T. S., Gonzalez, F. J., & Peters, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.020 · Cited by 34
Self-citationBility, M. T., Zhu, B., Kang, B. H., Gonzalez, F. J., & Peters, J. M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp212 · Cited by 34
Self-citationChen, F., Kim, E. S., Wang, C., & Harrison, L. E. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.012 · Cited by 32
Burton, J. D., Castillo, M. E., Goldenberg, D. M., & Blumenthal, R. D. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280200414 · Cited by 32
Peters, J. M., Morales, J. L., & Gonzalez, F. J. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.11.002 · Cited by 32
Self-citationAhmed, N., Riley, C. B., & Quinn, M. A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604306 · Cited by 31
Delage, B., Rullier, A., Capdepont, M., Rullier, É., & Cassand, P. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-20 · Cited by 30
Bräutigam, K., Biernath-Wüpping, J., Bauerschlag, D., von Kaisenberg, C. S., Jonat, W., Maass, N., Arnold, N., & Meinhold-Heerlein, I. M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0952-2 · Cited by 29
Schwartz, G. K., Weitzman, A., O'Reilly, E. M., Brail, L. H., de Alwis, D. P., Cleverly, A., Barile, B., Vinciguerra, V. P., & Budman, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.766 · Cited by 28
Davidson, B., Hadar, R., Stavnes, H. T., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.09.019 · Cited by 25
Knutsen, H. K., Ølstørn, H. B., Paulsen, J. E., Husøy, T., Goverud, I. L., Løberg, E. M., Kristiansen, K., & Alexander, J. (2005) · PubMed · Cited by 25
A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers
Read, W. L., Baggstrom, M. Q., Fracasso, P. M., & Govindan, R. (2008) · Chemotherapy · doi:10.1159/000140468 · Cited by 24
PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner
Meißner, M., Hrgović, I., Doll, M., & Kaufmann, R. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1091-y · Cited by 24
Lim, H., Park, J., Lee, S., Choi, H., Lee, K., & Park, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.002 · Cited by 24
Kim, D. J., Prabhu, K. S., Gonzalez, F. J., & Peters, J. M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi346 · Cited by 24
Self-citationKasuga, J.-I., Ishida, S., Yamasaki, D., Makishima, M., Doi, T., Hashimoto, Y., & Miyachi, H. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.021 · Cited by 23
Röhrl, C., Kaindl, U., Koneczny, I., Hudec, X., Baron, D. M., König, J. S., & Marian, B. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0856-1 · Cited by 23
Hamaguchi, N., Hamada, H., Miyoshi, S., Irifune, K., Ito, R., Miyazaki, T., & Higaki, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01632.x · Cited by 23
Zhu, B., Bai, R., Kennett, M. J., Kang, B.-H., Gonzalez, F. J., & Peters, J. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0820 · Cited by 23
Self-citationYoshinaga, M., Kitamura, Y., Chaen, T., Yamashita, S., Tsuruta, S., Hisano, T., Ikeda, Y., Sakai, H., Nakamura, K., Takayanagi, R., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0465-x · Cited by 20
Tenenbaum, A., Boyko, V., Fisman, E. Z., Goldenberg, I., Adler, Y., Feinberg, M. S., Motro, M., Tanné, D., Shemesh, J., Schwammenthal, E., et al. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-18 · Cited by 20
Quantitative analysis of PPARδ mRNA by real-time RT-PCR in 86 rectal cancer tissues
Yang, L., Zhou, Z., Luo, H., Zhou, B., Xia, Q. J., & Tian, C. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.11.005 · Cited by 18
Park, B.-H., Lee, S.-B., Stolz, D. B., Lee, Y. J., & Lee, B.-C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191718 · Cited by 17
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
Glazer, R., Yuan, H.-Y., Xie, Z., & Yin, Y.-Z. (2008) · PPAR Research · doi:10.1155/2008/247379 · Cited by 10
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Beyaz, S., Mana, M. D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.-J., Bauer-Rowe, K. E., Xifaras, M. E., Akkad, A., Arias, E., et al. (2016) · Nature · doi:10.1038/nature17173 · Cited by 845
Mirza, A. Z., Althagafi, I. I., & Shamshad, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.067 · Cited by 544
Brase, R. A., Mullin, E. J., & Spink, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030995 · Cited by 374
Metadata
- Authors
- Peters, J. M., Shah, Y. M., & Gonzalez, F. J.
- Venue
- Nature Reviews Cancer
- Published
- 2012-02-09
- Volume
- 12
- Issue
- 3
- Pages
- 181-195
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2034131665
- Cited by
- 492
- References
- 225
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.